Archive - February 2025
FDA Grants Priority Review to Merck’s Keytruda for Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma
FDA Approves First Treatment for Rare Lipid Storage Disease Cerebrotendinous Xanthomatosis
Ladrones de Ozempic: la nueva ola delictiva en Brasil
Opinion: What academic research could learn from college athletics
Decades of LDT Tension Leads to an Epic Three-Hour Oral Argument
FDA Approves Prolacta Bioscience’s Surgifort for Infants Recovering from Gastroschisis Surgery
Savings and Sustainability Sought by Pharma Partners
STAT+: Under siege after a tragedy, UnitedHealth grapples with fresh security threats and a customer backlash